MetaBrand Capital

MetaBrand Capital employs a direct investment model across buyout, growth, and early-stage opportunities. It pairs capital with operational integration through its parent company's FDA and TTB registered manufacturing facility in Edison, NJ, allowing portfolio companies to access in-house formulation services, quality control, and co-packing capacity. This structure contrasts with passive minority-investment or fund-of-funds approaches common elsewhere in consumer goods.

The MetaBrand platform has developed a wide range of beverage products including sports drinks, energy shots, nootropic RTDs, teas, plant-based elixirs, and alcohol-infused ready-to-drink cocktails. Its independent formulation team leverages a proprietary library of flavors, extracts, and ingredients, enabling clients and portfolio brands to commercialize products across non-alcoholic and alcoholic categories.

No publicly available information indicates that MetaBrand Capital operates through traditional fund structures. The firm describes itself as an investment arm aligned with its operating business, suggesting a direct-investment and permanent-capital approach rather than a blind-pool venture or buyout fund model. No filings for pooled investment vehicles are associated with the entity.

Craig Fortin and Nick Andlinger are identified as the leaders of MetaBrand. They oversee the capital deployment strategy as well as the broader MetaBrand Corp platform, which includes formulation, manufacturing, and strategic advisory services for beverage brands. Biographies and precise titles are not detailed on the firm's website.

MetaBrand manufactures for both clients that develop formulas through its services and clients who bring their own formulations, indicating the facility operates as a multi-tenant co-packer accessible beyond its own investment portfolio. However, the firm emphasizes the advantage its capital partners gain from controlling the manufacturing process to ensure accuracy and quality.